Anti‐<scp>GAD</scp> Antibodies as an Etiology of Cerebral Cortical Encephalitis: 2 Case Reports
CCE could be a new manifestation of anti-GAD antibodies, with distinct features compared to anti-MOG antibodies related to CCE. We recommend screening for anti-GAD antibodies in the context of CCE, especially in case of atypical features for MOG antibodies-associated disease (MOGAD).
Authors
- Bruno Lemarchant (ORCID: https://orcid.org/0000-0001-6828-3877)
- Cristina Birzu (ORCID: https://orcid.org/0000-0002-6781-7301)
- Stéphanie Rogeau
- Dimitri Psimaras (ORCID: https://orcid.org/0000-0002-6641-288X)
- Hélène Zéphir (ORCID: https://orcid.org/0000-0003-4029-2012)
- Delphine Leclercq (ORCID: https://orcid.org/0000-0003-1110-3833)
- Louis Cousyn (ORCID: https://orcid.org/0000-0003-1407-5575)
Institutions
- Inserm (FR)
- Université de Lille (FR)
- Centre Hospitalier Universitaire de Lille (FR)
- Sorbonne Université (FR)
- Pitié-Salpêtrière Hospital (FR)
- Institut du Cerveau (FR)
Publication Details
- Journal
- European Journal of Neurology
- Published
- 2025-02-28
- DOI
- https://doi.org/10.1111/ene.70096
- Primary Topic
- Autoimmune Neurological Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00